Summary
It has become increasingly popular to carry out cost-effectiveness analyses in economic evaluations of healthcare programmes. Cost-effectiveness analysis is based on the maximisation of the health effects for a given amount of resources. However, many published studies fail to report the results of cost-effectiveness analysis in a way that is consistent with this underlying aim. The aim of this article is to demonstrate the decision rules of cost-effectiveness analysis in an easily accessible way for practitioners in the field. A hypothetical example is used to demonstrate the decision rules of cost-effectiveness analysis, and we also show how to estimate the appropriate incremental cost-effectiveness ratios and how to exclude dominated alternatives. It is then shown how fixed budgets or predetermined prices per effectiveness unit can be used as decision rules to maximise health effects and to determine which programmes to implement on the basis of incremental cost-effectiveness ratios. We hope that the article will contribute towards an increased understanding and application of the appropriate decision rules of cost-effectiveness analysis, so that the results of cost-effectiveness analyses can be interpreted meaningfully by decision makers.
Similar content being viewed by others
References
Weinstein MC, Zeckhauser R. Critical ratios and efficient allocation. J Public Econ 1973; 2: 147–57
Weinstein M. Principles of cost-effective resource allocation in health care organisations. Int J Technol Assess Health Care 1990; 6: 93–105
Karlsson G. Economic evaluation of dental implants [in Swedish]. Linköping Studies in Arts and Science 69. Linköping: Linköping University, 1991
Johannesson M, Weinstein MC. On the decision rules of cost-effectiveness analysis. J Health Econ 1993; 12: 459–67
Sintonen H, Alander V. Comparing the cost-effectiveness of drug regimens in the treatment of duodenal ulcers. J Health Econ 1990; 9: 95–101
Buxton MJ, O’Brien BJ. Economic evaluation of ondansetron: preliminary analysis using clinical trial data prior to price setting. Br J Cancer 1992; 66 Suppl.: S64–7
Garattini L, Grilli R, Scopelliti D, et al. A proposal for Italian guidelines in pharmacoeconomics. PharmacoEconomics 1995; 7: 1–6
Kawachi I, Malcolm LA. The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal. J Hypertens 1991; 9: 199–208
Johannesson M. The relationship between cost-effectiveness analysis and cost-benefit analysis. Soc Sci Med 1995; 41: 483–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karlsson, G., Johannesson, M. The Decision Rules of Cost-Effectiveness Analysis. Pharmacoeconomics 9, 113–120 (1996). https://doi.org/10.2165/00019053-199609020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199609020-00003